Alpha Tau Medical (DRTS) EPS (Basic) (2021 - 2026)

Alpha Tau Medical has reported EPS (Basic) for 6 years, with the latest figure at $0.26 in Q1 2026.

• Quarterly EPS (Basic) rose 109.68% year-over-year to $0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.63 (up 37.96% YoY) and the FY2025 annual result came in at $0.53, up 15.89% from the prior year.
• EPS (Basic) rose to $0.26 in Q1 2026 per DRTS's latest filing, from $0.15 in the prior quarter.
• Over five years, EPS (Basic) peaked at $0.54 in Q1 2022 and troughed at $0.03 in Q2 2022.
• A 5-year average of $0.16 and a median of $0.12 in 2025 frame the typical range for EPS (Basic).
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 80.04% in 2022, then surged 725.78% in 2023.
• Over 5 years, EPS (Basic) stood at $0.05 in 2022, then soared by 98.53% to $0.11 in 2023, then grew by 27.88% to $0.14 in 2024, then advanced by 11.83% to $0.15 in 2025, then soared by 68.82% to $0.26 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $0.26, $0.15, and $0.15 for Q1 2026, Q4 2025, and Q3 2025 respectively.